Objectives
• Review data surrounding risks associated with Peripheral IVs (PIVs)
• Discuss how care and maintenance of PIVs relates to the changing healthcare landscape
• Identify strategies to lessen risks associated with PIV complications and sequelae
BSI Definitions
• CR-BSI Catheter Related BSI 1
• A clinical definition used when diagnosing & treating patients • More thoroughly identifies the catheter as the source • Not used for surveillance
• CLA-BSI -Central Line Associated BSI 2
• Used for surveillance • A laboratory-confirmed bloodstream infection (LCBI) where central line (CL) or umbilical catheter (UC) was
• in place for >2 calendar days on the date of event, with day of device placement being Day 1 AND • in place on the date of event or the day before. 
Primary

Trinh (continued)
• Antecubital fossa (67%)
• Placement in Emergency Room (67%)
• Placement outside of the hospital (16%)
• 2 from outside facilities • 150 catheter-related infections (147 pts)
• 77 PVC-related (0.19 per 1,000 pt days)
• 73 CVC-related (0.18 per 1,000 pt days)
• PVC related infections originated from lines placed in the ER 42% of the time
• No CVCs were placed in ER
• S. aureus more prevalent as pathogen in PIV vs. CVC (53% vs. 33%)
A Comparison of Bloodstream Infections in Central and Peripheral Venous Catheters
Pujol (continued)
• Number of days to onset Not Without Risk • Subsequently 
Results:
• Changing for clinical need rather than on routine schedule reduced the rate of bacteremia 44%
-OR = 0.57 P= 0.37
• 24% increase in phlebitis in the clinical change group -OR= 1.24 P=0.09
Cochrane Update 2013
• Seven additional trials were reviewed with a total of 4895 patients 
Lancet summary
• Routine replacement increases:
• Costs • Staff time • Number of procedures patients must undergo
• We need to think about getting our dwell time to be our average length of staff, and we will be saving our patients from needless restarts
• 5907 catheters in randomized, multi-center study 
